Figure 3
- ID
- ZDB-IMAGE-260729-40
- Publication
- Zafar et al., 2026 - A Preliminary Zebrafish Model of ACTA2 Deficiency Reveals Increased Larval Phenotype Burden and Suggests Reduced Adult Mutant Survival
- All Figures
- Figures for Zafar et al., 2026
Figure 3
Group-specific proportions of adverse larval phenotypes by genotype and treatment. Phenotype occurrence is shown across the 2 × 2 study design defined by genotype (Normal vs. Mutant [acta2−/−]) and treatment (control [DMSO] vs. Epinephrine). Panels display the proportion of larvae with any phenotype, axis defects, edema, or hemorrhage. Bars represent group-specific proportions, and error bars indicate 95% confidence intervals. For each endpoint, proportions were calculated using the number of fish with observed data for that outcome as the denominator. Four prespecified pairwise comparisons were performed within each panel using Pearson’s chi-squared tests: Normal control vs. Normal Epinephrine, Mutant control vs. Mutant Epinephrine, Normal control vs. Mutant control, and Normal Epinephrine vs. Mutant Epinephrine. Exact p-values are shown above the corresponding brackets. Corresponding counts and proportions are provided in Table 2B.